Patents by Inventor Joseph Orgel

Joseph Orgel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10336814
    Abstract: A collagen material having a form of thin fibrils generally free of fibril-bundling proteogylcan interactions, and a method for providing the thin fibril collagen material from native collagen fibers. The method uses proteoglycan antibodies to disassociate the proteoglycan interactions in bundled collagen fibrils to provide the constituent fibrils. The process can be used as a model for arthritis and the resulting fibrils can be used to form new extracellular matrix biomaterials and new tissues.
    Type: Grant
    Filed: September 6, 2016
    Date of Patent: July 2, 2019
    Assignee: MATRIX ODYSSEY, LLC
    Inventors: Joseph Orgel, Olga Antipova
  • Publication number: 20160368968
    Abstract: A collagen material having a form of thin fibrils generally free of fibril-bundling proteogylcan interactions, and a method for providing the thin fibril collagen material from native collagen fibers. The method uses proteoglycan antibodies to disassociate the proteoglycan interactions in bundled collagen fibrils to provide the constituent fibrils. The process can be used as a model for arthritis and the resulting fibrils can be used to form new extracellular matrix biomaterials and new tissues.
    Type: Application
    Filed: September 6, 2016
    Publication date: December 22, 2016
    Inventors: Joseph Orgel, Olga Antipova
  • Patent number: 9458224
    Abstract: A collagen material having a form of thin fibrils generally free of fibril-bundling proteogylcan interactions, and a method for providing the thin fibril collagen material from native collagen fibers. The method uses proteoglycan antibodies to disassociate the proteoglycan interactions in bundled collagen fibrils to provide the constituent fibrils. The process can be used as a model for arthritis and the resulting fibrils can be used to form new extracellular matrix biomaterials and new tissues.
    Type: Grant
    Filed: April 7, 2009
    Date of Patent: October 4, 2016
    Assignee: Matrix Odyssey, LLC
    Inventors: Joseph Orgel, Olga Antipova
  • Publication number: 20100255457
    Abstract: A collagen material having a form of thin fibrils generally free of fibril-bundling proteogylcan interactions, and a method for providing the thin fibril collagen material from native collagen fibers. The method uses proteoglycan antibodies to disassociate the proteoglycan interactions in bundled collagen fibrils to provide the constituent fibrils. The process can be used as a model for arthritis and the resulting fibrils can be used to form new extracellular matrix biomaterials and new tissues.
    Type: Application
    Filed: April 7, 2009
    Publication date: October 7, 2010
    Inventors: Joseph Orgel, Olga Antipova